Trial intelligence / Profile preview

Levosimendan in Acute Kidney Injury After Cardiac Surgery

NCT02531724Phase 4Completed

Sponsor
Sahlgrenska University Hospital
Start
Sep 2015
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levosimendan in acute kidney injury (AKI), sponsored by Sahlgrenska University Hospital. Started Sep 2015; status: completed.

02

Drugs

levosimendan
03

Conditions

acute kidney injury (AKI)

Beyond the preview

Go deeper on NCT02531724.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02531724.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call